4-Aminopyridine CAS 504-24-5 Assay ≥99.5% (HPLC) Factory
Phepelo ea Moetsi, Bohloeki bo Phahameng, Tlhahiso ea Khoebo
Lebitso la lik'hemik'hale: 4-Aminopyridine
CAS: 504-24-5
| Lebitso la Lik'hemik'hale | 4-Aminopyridine |
| Litlhaloso tse tšoanang | 4-AP;4-Pyridinamine;Fampridine;Dalfampridine;p-aminopyridine;γ-Aminopyridine |
| Nomoro ea CAS | 504-24-5 |
| Nomoro ea KAtse | RF-PI539 |
| Boemo ba Setoko | Ka Setokong, Sekhahla sa Tlhahiso Ho fihlela ho Lithane |
| Foromo ea limolek'hule | C5H6N2 |
| Boima ba Molek'hule | 94.12 |
| Solubility | E qhibiliha ka Metsing, Ethanol |
| Brand | Ruifu Chemical |
| Ntho | Litlhaloso |
| Ponahalo | Phofo ea Crystalline e Bosoeu kapa e Hanyane hanyenyane |
| Mokhoa oa ho hlahloba / oa ho hlahloba | ≥99.5% (HPLC) |
| Melting Point | 157.0 ~ 162.0℃ |
| Metsi (KF) | ≤0.50% |
| Molora oa Sulfate | ≤0.20% |
| 2-Aminopyridine | ≤0.10% |
| 3-Aminopyridine | ≤0.10% |
| Litšila ka Kakaretso | ≤0.50% |
| Tekanyetso ea Teko | Maemo a Khoebo |
| Tšebeliso | Li-Intermediates tsa Meriana;API |
Sephutheloana: Botlolo, Aluminium foil bag, 25kg/Cardboard Drum, kapa ho ea ka tlhokahalo ea moreki.
Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa leseli le mongobo.
4-Aminopyridine (CAS: 504-24-5) ke e 'ngoe ea li-amine tse tharo tsa isomeric tsa pyridine, ke motsoako o hloekileng haholo, oa maiketsetso le oa biologically, o sebelisoang haholo ho organic synthesis, synthesis of pharmaceutical intermediates le Active Pharmaceutical Ingredient (API). ) kopanyo.4-Aminopyridine (4-AP, Fampridine, Dalfampridine) e sebelisoa e le sesebelisoa sa ho etsa lipatlisiso ho khethollang li-subtypes tsa mocha oa potassium.E boetse e sebelisitsoe e le lithethefatsi, ho laola tse ling tsa matšoao a multiple sclerosis, 'me e bontšoa bakeng sa ntlafatso ea matšoao a ho tsamaea ho batho ba baholo ba nang le mefuta e mengata ea lefu lena.US Food and Drug Administration (FDA) e amohetse kompone ka la 22 Pherekhong 2010. Fampridine e boetse e rekisoa United States ke Acorda Therapeutics le e le Fampyra European Union, Canada, le Australia.
